App-Quantinova.ai

The impact of patient characteristics on lifetime risk of revision following knee and hip replacement: evidence from linked primary care and hospital records

E. Burn - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

Prevalence and factors associated with self-reported fatigue in individuals with symptomatic knee osteoarthritis: the most study

H.O. Fawole - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Relation of radiographic severity of knee osteoarthritis to clinical pain scores: results from the pain perception in osteoarthritis study

L. Assi - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Knee osteoarthritis

N/A

Triamcinolone acetonide extended-release injectable suspension (TA-ER) provides clinically relevant improvements in pain and function of knee osteoarthritis: a pooled analysis of 3 randomized clinical trials employing composite assessments

N.P. Katz - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

Triamcinolone acetonide

Triamcinolone acetonide extended-release injectable suspension (TA-ER) is associated with reduced blood glucose elevation vs. standard triamcinolone in type 2 diabetes mellitus patients with knee osteoarthritis: a randomized, blinded, parallel-group study

P.G. Conaghan - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Type 2 diabetes mellitus

Triamcinolone acetonide

MRI cartilage thickness and KL grades show different associations with osteoarthritis pain: a study using accurate 3D MRI data from 9592 normal and osteoarthritic knees in the OAI

O.A. Alabas - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Association of metabolic syndrome with knee and hand osteoarthritis: a community-based study of women

M.T. Sanchez-Santos - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Rheumatoid arthritis

N/A

A clinical assessment tool to improve the use of pain relieving treatments in knee osteoarthritis

K. Akin-Akinyosoye - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Knee osteoarthritis

N/A

Can depression, functional performance and kinesiophobia predict lower physical activity levels in patients with knee osteoarthritis?

G.I. Kinikli - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Knee osteoarthritis

N/A

Is playing position, playing standard or length of play associated with joint specific osteoarthritis in cricketers?

S.R. Filbay - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Osteoarthritis

N/A

A validation study of the Arabic version of the Oxford knee score for use in end stage knee osteoarthritis

B. Bin Sheeha - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

General practitioners' views on managing knee osteoarthritis: factors influencing clinical practice guideline implementation in primary care

T. Egerton - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Worsening adherence to OARSI guidelines for the non-operative management of hip and knee osteoarthritis

D.F. Hamilton - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Joint space width inclusion criteria can reduce knee osteoarthritis trial heterogeneity: post-hoc data from a phase 2 trial of wnt pathway inhibitor, SM04690

P. Conaghan - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

SM04690

Improving access to care and treatment for patients with hip and knee pain at the interface between primary and secondary care

K. Button - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Development of a service delivery intervention and implementation plan for optimising primary care management of knee osteoarthritis: the partner project

T. Egerton - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Current practice in methodology and reporting of the sample size calculation in randomised trials of hip and knee osteoarthritis: a systematic review

B. Copsey - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Evaluation of the self management of osteoarthritis and low back pain through activity and skills physiotherapist e-learning training programme compared to face to face training

D.A. Hurley - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Recruitment, randomization and retention: UK experience of the ‘3 RS’ in osteoarthritis drug trials targeting pain

S. Masters - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

The approach consortium: a 2-year, European, cohort study to describe, validate, and predict phenotypes of knee osteoarthritis by use of clinical, imaging, and biochemical markers

E.M. van Helvoort - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Filters

45280 Abstracts